Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Endologix Inc. ELGXQ

Endologix Inc develops, manufacture, market, and sell innovative medical devices for the treatment of aortic disorders in the United States and internationally. The company only reporting segment that is focused on the development, manufacture, marketing, and sale of EVAR and EVAS products for the treatment of aortic disorders. It product Includes a variety of endovascular stent grafts for the treatment of abdominal aortic aneurysms such as AFX Endovascular AAA System, VELA Proximal Endograft, a


OTCPK:ELGXQ - Post by User

Bullboard Posts
Post by investorblingon Feb 23, 2007 11:45am
197 Views
Post# 12297471

Recommendations for February 23, 2007 - Concorde

Recommendations for February 23, 2007 - Concorde

Concorde

Fording Canadian Coal Trust | Gary Lampard, FDG.UN : TSX : C$27.39 | C$4,026.3M | Sell , Target C$18.50

Distribution cuts likely for 2007; Downgrading estimates

Aurelian Resources Inc. | Graeme Currie, ARU : TSX-V : C$29.33 | C$997.2M | Speculative Buy , Target C$50.50

Further assays reported from the FDN zone

Western Canadian Coal | Gary Lampard, WTN : TSX : C$1.85 | C$165.2M | Buy , Target C$2.35

Wolverine ramping up now!

Noble Energy | Irene Haas, NBL : NYSE : US$58.69 | US$10,173.0M | Buy , Target US$67.00

Equatorial Guinea exploration drilling to start

PrimeWest Energy Trust | Bruce McDonald, PWI.UN : TSX : C$23.05 | C$2,067.0M | Buy , Target C$25.00

Q4 results in line, no changes to 2007 guidance, strong year-end 2006 reserve results; Raising target price to C$25.00

Enerplus Resources Fund | Bruce McDonald, ERF.UN : TSX : C$50.40 | C$6,206.8M | Buy , Target C$52.00

Q4 results above expectations, no change in 2007 guidance

Inter Pipeline Fund | Bob Hastings, IPL.UN : TSX : C$9.05 | C$1,825.4M | Hold , Target C$8.75

Distributable cash flow below expectations; all divisions operating well, but operating expenses and sustaining capex higher than anticipated

Vault Energy Trust | Bruce McDonald, VNG.UN : TSX : C$5.17 | C$198.0M | Buy , Target C$6.00

Assets appear to have stabilized - remains one of our top consolidation picks

Axia NetMedia Corp. | David Lambert, AXX : TSX : C$5.26 | C$347.7M | Buy , Target C$7.00

Axia's value added services could be underestimated

Universal Electronics | Steven B. Frankel, CFA, UEIC : NNM : US$22.54 | US$323.6M | Buy , Target US$27.00

Reports another solid quarter

Dot Hill Systems | Mark Kelleher, HILL : NNM : US$3.76 | 169.2M | Hold

Q4 report: Large hill to climb

BEA Systems Inc. | Peter Misek, BEAS : NNM : US$13.20 | US$5,474.4M | Buy , Target US$18.00

Q4 a mixed bag: AquaLogic strength offset by pockets of weakness in Asia and with WebLogic

Endologix | Matthew Scalo, ELGX : NNM : US$4.59 | US$195.7M | Buy , Target US$8.00

Good Q4; momentum builds and catalysts expected in 2007

Spectranetics | Matthew Scalo, SPNC : NNM : US$10.85 | 334.3M | Hold

TURBO Booster and ramp in profitability pushed out

Legacy Hotels REIT | Jonathan Kelcher, LGY.UN : TSX : C$10.90 | C$1,216.0M | Hold , Target C$11.00

Q4 results light but industry fundamentals strengthening; Increasing target price to C$11.00

Herbalife | Scott Van Winkle, CFA, HLF : NYSE : US$37.51 | US$2,785.4M | Buy , Target US$48.00

Q4 report won't drive stock

SunOpta | Scott Van Winkle, CFA, STKL : NNM : US$10.47 | US$608.3M | Buy , Target US$12.50

Quite a healthy Q4 with in-line pro forma EPS

Stantec Inc. | Sara Elford, STN : TSX : C$28.14 | C$1,271.9M | Buy , Target C$33.00

2006 results beat expectations, outlook still strong, raising target to C$33.00

Interface | Eric Glover, CFA, IFSIA : NNM : US$16.46 | US$1,005.0M | Buy , Target US$22.00

Raising estimates following strong Q4 earnings

 

Bullboard Posts